GlassScriptPhysician profile
Cathy Ann Morimando
NPI 1346228772
$1,668.38
in general payments reported to CMS, 2019-2025
10 companies · $171 in 2025
The $171 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $256 · 2022: $575 · 2023: $246 · 2024: $420 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $837.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $837.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $678.06 | 2021-2025 | Jot Dx, Xience Sierra, Aveir |
| Medtronic, INC. | $314.17 | 2021-2024 | Azure Xt Dr Mri Surescan, Micra |
| Boston Scientific Corporation | $220.90 | 2022-2024 | Ingevity+, Lux-Dx Insertable Cardiac Monitor, S-Icd System Magnet |
| Abiomed | $160.02 | 2024-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $100.26 | 2021-2024 | Lifevest |
| Kestra Medical Technology Services, INC. | $66.53 | 2024-2025 | Assure Wcd |
| Lantheus Medical Imaging, INC. | $65.98 | 2023-2024 | Definity |
| Biotronik INC. | $28.24 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $19.99 | 2021 | |
| Novo Nordisk INC | $14.23 | 2023 | Rybelsus, Ozempic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cathy Morimando listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.